Tsuyusaki H, Kondo R, Murase S, Yoshiyama Y, Kobayashi T, Takagi H, Kitahara Y, Morii S, Tomonaga F, Ohwada T
Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan.
Acta Neurochir Suppl (Wien). 1994;60:550-1. doi: 10.1007/978-3-7091-9334-1_152.
To clarify the pharmacokinetics and effect of ICP reduction of glycerol administered orally, the serum concentration of glycerol was measured by the enzymatic method and ICP was measured by the subdural balloon method in severe head injured patients with brain edema and increased ICP. Sequential change of serum glycerol concentration and its relationship to the reduction of ICP were analyzed. The results showed that the pharmacokinetics of glycerol through oral administration were similar to that of intravenous glycerol administration and the changes of ICP were also similar to that of intravenous glycerol administration. We determined that glycerol can be administered either per oral or per venous to obtain the same results for treatment of brain edema with raised ICP.
为阐明口服甘油降低颅内压(ICP)的药代动力学及效果,采用酶法测定重度颅脑损伤合并脑水肿及ICP升高患者的血清甘油浓度,采用硬膜下球囊法测定ICP。分析血清甘油浓度的动态变化及其与ICP降低的关系。结果表明,口服甘油的药代动力学与静脉注射甘油相似,ICP的变化也与静脉注射甘油相似。我们确定,口服或静脉注射甘油均可获得相同的效果,用于治疗ICP升高的脑水肿。